Provectus Biopharmaceuticals, Inc. (PVCT): Shares Outstanding
420.28M
As of 2025-12-31
420.28M
As of 2026-06-30
+0.1%
3-year compound annual growth
+1.1%
5-year compound annual growth
+7.4%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 420.28M | 0.0% | 2026-03-26, Balance as of period end |
| 2024-12-31 | 420.28M | +0.2% | 2026-03-26, Balance as of period end |
| 2023-12-31 | 419.52M | 0.0% | 2025-03-28, Balance as of period end |
| 2022-12-31 | 419.45M | 0.0% | 2024-03-28, Balance as of period end |
| 2021-12-31 | 419.45M | +5.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | 398.81M | +2.3% | 2022-03-29, Balance as of period end |
| 2019-12-31 | 389.89M | +1.4% | 2021-03-02, Balance as of period end |
| 2018-12-31 | 384.61M | +3.7% | 2020-03-05, Balance as of period end |
| 2017-12-31 | 370.96M | +1.7% | 2019-03-07, Balance as of period end |
| 2016-12-31 | 364.77M | +78.0% | 2018-03-23, Balance as of period end |
| 2015-12-31 | 204.98M | +10.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | 184.80M | +15.7% | 2016-03-30, Balance as of period end |
| 2013-12-31 | 159.75M | +34.9% | 2015-03-12, Balance as of period end |
| 2012-12-31 | 118.43M | +7.1% | 2014-03-13, Balance as of period end |
| 2011-12-31 | 110.60M | +21.1% | 2013-03-14, Balance as of period end |
| 2010-12-31 | 91.30M | n/a | 2012-03-14, Balance as of period end |